445 related articles for article (PubMed ID: 32573567)
1. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.
Wang G; Jiao T; Xu Y; Li D; Si Q; Hao J; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jul; 11(7):6115-6127. PubMed ID: 32573567
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice.
Kim B; Park KY; Ji Y; Park S; Holzapfel W; Hyun CK
Biochem Biophys Res Commun; 2016 Apr; 473(2):530-6. PubMed ID: 27018382
[TBL] [Abstract][Full Text] [Related]
3.
Wang B; Kong Q; Cui S; Li X; Gu Z; Zhao J; Zhang H; Chen W; Wang G
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801119
[TBL] [Abstract][Full Text] [Related]
4.
Long X; Liu D; Gao Q; Ni J; Qian L; Ni Y; Fang Q; Jia W; Li H
Front Endocrinol (Lausanne); 2021; 12():773340. PubMed ID: 35035378
[TBL] [Abstract][Full Text] [Related]
5. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners.
Wang G; Si Q; Yang S; Jiao T; Zhu H; Tian P; Wang L; Li X; Gong L; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jul; 11(7):5898-5914. PubMed ID: 32572400
[TBL] [Abstract][Full Text] [Related]
6.
Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
[TBL] [Abstract][Full Text] [Related]
7. Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation.
Wang T; Yan H; Lu Y; Li X; Wang X; Shan Y; Yi Y; Liu B; Zhou Y; Lü X
Eur J Nutr; 2020 Sep; 59(6):2709-2728. PubMed ID: 31659451
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
[TBL] [Abstract][Full Text] [Related]
9.
Wang L; Jiao T; Yu Q; Wang J; Wang L; Wang G; Zhang H; Zhao J; Chen W
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052765
[TBL] [Abstract][Full Text] [Related]
10.
Nguyen HT; Gu M; Werlinger P; Cho JH; Cheng J; Suh JW
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362221
[TBL] [Abstract][Full Text] [Related]
11. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity.
Le Barz M; Daniel N; Varin TV; Naimi S; Demers-Mathieu V; Pilon G; Audy J; Laurin É; Roy D; Urdaci MC; St-Gelais D; Fliss I; Marette A
FASEB J; 2019 Apr; 33(4):4921-4935. PubMed ID: 30596521
[TBL] [Abstract][Full Text] [Related]
12.
Lee NY; Yoon SJ; Han DH; Gupta H; Youn GS; Shin MJ; Ham YL; Kwak MJ; Kim BY; Yu JS; Lee DY; Park TS; Park SH; Kim BK; Joung HC; Choi IS; Hong JT; Kim DJ; Han SH; Suk KT
Gut Microbes; 2020 Jul; 11(4):882-899. PubMed ID: 31965894
[TBL] [Abstract][Full Text] [Related]
13. High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE
Chan YK; Brar MS; Kirjavainen PV; Chen Y; Peng J; Li D; Leung FC; El-Nezami H
BMC Microbiol; 2016 Nov; 16(1):264. PubMed ID: 27821063
[TBL] [Abstract][Full Text] [Related]
14. A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption.
Jang HR; Park HJ; Kang D; Chung H; Nam MH; Lee Y; Park JH; Lee HY
Exp Mol Med; 2019 Aug; 51(8):1-14. PubMed ID: 31409765
[TBL] [Abstract][Full Text] [Related]
15. Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism.
Chen YH; Chiu CC; Hung SW; Huang WC; Lee YP; Liu JY; Huang YT; Chen TH; Chuang HL
Nutr Res; 2019 Sep; 69():20-29. PubMed ID: 31470288
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease.
Mouzaki M; Bandsma R
Curr Drug Targets; 2015; 16(12):1324-31. PubMed ID: 25882223
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
Zhao C; Liu L; Liu Q; Li F; Zhang L; Zhu F; Shao T; Barve S; Chen Y; Li X; McClain CJ; Feng W
Mol Metab; 2019 Nov; 29():145-157. PubMed ID: 31668386
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model.
Park S; Kang J; Choi S; Park H; Hwang E; Kang YG; Kim AR; Holzapfel W; Ji Y
PLoS One; 2018; 13(8):e0203150. PubMed ID: 30153290
[TBL] [Abstract][Full Text] [Related]
19. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
20. Specific Strains of
Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
